Cognic-E Nutraceutical Drug Development Service

The government authority in California requires a USA-based onshore organization to provide end-to-end Cognic-E nutraceutical drug development services. The selected supplier must develop an aqueous combination formulation of two nutraceuticals, nicotinamide and EGCG. Scope responsibilities include identifying information gaps, conducting further formulation development if needed, performing phase-appropriate testing, documenting assumptions, and preparing Chemistry, Manufacturing, and Controls documentation along with phase-appropriate source documents to support the submission strategy. The buyer is looking for proposals to establish the budget. Interested bidders can submit responses digitally via email or online. The buyer will hold a pre-bid meeting on September 2, 2026, and requires all questions to be submitted no later than September 7, 2026.